Skip to Content

BlackRock Advantage International Inv A BROAX

Medalist Rating as of | See BlackRock Investment Hub
  • NAV / 1-Day Return 18.30  /  +0.16 %
  • Total Assets 1.6 Bil
  • Adj. Expense Ratio
    0.750%
  • Expense Ratio 0.750%
  • Distribution Fee Level Low
  • Share Class Type Front Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 2.52%
  • Turnover 128%

USD | NAV as of Feb 23, 2024 | 1-Day Return as of Feb 23, 2024, 11:10 PM GMT+0

Morningstar’s Analysis BROAX

Will BROAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Strict adherence to the benchmark limits this strategy’s appeal.

Analyst Paul Ruppe

Paul Ruppe

Analyst

Summary

BlackRock Advantage International’s well-stocked research team and its respectable but unexceptional quantitative approach earn it a Morningstar Analyst Rating of either Bronze or Neutral, depending on share class fees.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings BROAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 20.2
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

3.19 48.4 Mil
Healthcare

Nestle SA

2.74 41.6 Mil
Consumer Defensive

ASML Holding NV

2.48 37.6 Mil
Technology

BlackRock Liquidity T-Fund Instl

2.44 37.1 Mil
Cash and Equivalents

Novartis AG Registered Shares

2.13 32.4 Mil
Healthcare

SAP SE

1.96 29.8 Mil
Technology

BHP Group Ltd

1.84 28.0 Mil
Basic Materials

Siemens AG

1.72 26.1 Mil
Industrials

Tokyo Electron Ltd

1.46 22.2 Mil
Technology

Deutsche Telekom AG

1.35 20.6 Mil
Communication Services